Avalo Therapeutics, INC. (AVTX) — 8-K/A Filings

All 8-K/A filings from Avalo Therapeutics, INC.. Browse 2 Amended Current Event Report reports with AI-powered summaries and risk analysis.

8-K/A Filings (2)

Avalo Therapeutics Files Amendment to 8-K — Jun 24, 2024 Risk: low
Avalo Therapeutics, Inc. filed an amendment (No. 2) to its Form 8-K on March 27, 2024, originally filed on March 28, 2024. This amendment primarily concerns the
Avalo Therapeutics Files Amendment to 8-K — Jun 3, 2024 Risk: low
Avalo Therapeutics, Inc. filed an amendment (Amendment No. 1) to its Form 8-K on March 27, 2024, which was filed on March 28, 2024. This amendment pertains to I

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX